Herrmann John A III

Avg. Two Year Performance

No purchase track record
< 1% Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%< 1%< 1%< 1%< 1%
Sale Success Rate1 of 151 of 151 of 151 of 151 of 15
Drugs » Biotechnology

EVP, Chief Legal Officer:

Holdings: 13.23K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--